2025 ASCO Annual Meeting Presentation
May 30, 2025, 5:00:00 AM — clinical readout
Summary
Perspective Therapeutics will present data on its [212Pb]VMT-α-NET and [212Pb]VMT01 programs at the 2025 ASCO Annual Meeting in Chicago, IL, from May 30 to June 3, 2025.
Company
PERSPECTIVE THERAPEUTICS INC (CATX)NYSEMKT — Healthcare: Manufacturing, Medical Devices: Surgical & Medical Instruments & Apparatus
www.isoray.comSimilar Events
Poster Presentation at ASCO 2025
Merus will present updated interim clinical data for petosemtamab at the ASCO Annual Meeting on June 2, 2025, showcasing results from a phase 2 trial in HNSCC.
clinical readoutASCO Annual Meeting Oral Presentation
Candel Therapeutics will present data from its phase 3 clinical trial of CAN-2409 for localized prostate cancer at the ASCO Annual Meeting from May 30 to June 3, 2025.
clinical readoutASCO Abstract Release
The American Society of Clinical Oncology will release further details for regular abstracts on Perspective Therapeutics' programs on May 22, 2025, at 5:00 PM EDT.
otherPresentation at ASCO Annual Meeting 2025
Results from Novocure's Phase 3 PANOVA-3 trial in pancreatic cancer will be presented as a late-breaking abstract at the 2025 ASCO Annual Meeting.
clinical readout